Drug Trial Radar · NCT01746485
Three Times Daily Dosing of UT-15C
Last checked: Nov 20, 2026Latest source record: Dec 12, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
19
Actual
Start
Jul 2012
Primary completion
Jul 2012
Study completion Jul 2012
Sponsor
- Lead sponsor
- United TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Dec 11, 2012
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To evaluate the pharmacokinetics of three-times daily dosing of UT-15C in healthy volunteers
Conditions
- Healthy
Interventions
UT-15CDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under the curve (AUC) from 0-24hrs after 6 days of TID dosing.Time frame: 6 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
PPD Development
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.